Society Letters

Letter to Congressional Leadership About Biosimilar Insulin

November 24, 2020

To: The Honorable Mitch McConnell, The Honorable Chuck Schumer, The Honorable Nancy Pelosi, The Honorable Kevin McCarthy

"As Congress considers its end-of-the-year priorities, the undersigned organizations representing patients, providers, and taxpayers strongly encourage you to enact this bipartisan fix to encourage greater adoption and use of lower-cost biosimilar medicines. We believe this modest proposal – which the Congressional Budget Office scored as revenue neutral6 – would move us closer to fulfilling the promise of biosimilars and helping millions of patients who live with chronic conditions."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!